The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16400650
Conclusion of this study
The current study findings suggested that menatetrenone may have a suppressive effect on recurrence of HCC and a beneficial effect on survival, although a larger, placebo-controlled trial will be required to prove these effects.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study